Egerer G - Search Results

1

Is there an indication for high-dose chemotherapy in the treatment of bone and soft-tissue sarcoma?

Kasper B, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Oncology. 2005;68(2-3):115-21. doi: 10.1159/000085704. Epub 2005 May 9. Oncology. 2005. PMID: 15886503 Review.

2

P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.

Hensel M, Schneeweiss A, Sinn HP, Egerer G, Solomayer E, Haas R, Bastert G, Ho AD. Hensel M, et al. Among authors: egerer g. Int J Cancer. 2002 Jul 20;100(3):290-6. doi: 10.1002/ijc.10478. Int J Cancer. 2002. PMID: 12115543

3

Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?

Kasper B, Harter C, Meissner J, Bellos F, Krasniqi F, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Support Care Cancer. 2004 Mar;12(3):205-7. doi: 10.1007/s00520-003-0573-2. Epub 2004 Jan 16. Support Care Cancer. 2004. PMID: 14727169

4

A new therapeutic approach in patients with advanced sarcoma.

Kasper B, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Int J Clin Oncol. 2005 Dec;10(6):438-40. doi: 10.1007/s10147-005-0514-9. Int J Clin Oncol. 2005. PMID: 16369750

5

Dose-intensive chemotherapy with stem cell support as a treatment strategy for bone and soft-tissue sarcomas.

Kasper B, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Curr Stem Cell Res Ther. 2006 Jan;1(1):29-35. doi: 10.2174/157488806775269098. Curr Stem Cell Res Ther. 2006. PMID: 18220851

6

Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.

Kasper B, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Haberkorn U, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Onkologie. 2008 Mar;31(3):107-12. doi: 10.1159/000113795. Epub 2008 Feb 8. Onkologie. 2008. PMID: 18322413 Clinical Trial.

7

Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.

Kasper B, Dietrich S, Mechtersheimer G, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Oncology. 2007;73(1-2):58-64. doi: 10.1159/000120629. Epub 2008 Mar 11. Oncology. 2007. PMID: 18334832

8

The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.

Kasper B, Schmitt T, Wuchter P, Dimitrakopoulou-Strauss A, Ho AD, Egerer G. Kasper B, et al. Among authors: egerer g. Mar Drugs. 2009 Jul 17;7(3):331-40. doi: 10.3390/md7030331. Mar Drugs. 2009. PMID: 19841717 Free PMC article.

9

Trabectedin for metastatic soft tissue sarcoma: a retrospective single center analysis.

Schmitt T, Keller E, Dietrich S, Wuchter P, Ho AD, Egerer G. Schmitt T, et al. Among authors: egerer g. Mar Drugs. 2010 Oct 13;8(10):2647-58. doi: 10.3390/md8102647. Mar Drugs. 2010. PMID: 21116412 Free PMC article.

10

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.

Schmitt T, Lehner B, Kasper B, Bischof M, Roeder F, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Mechtersheimer G, Wuchter P, Ho AD, Egerer G. Schmitt T, et al. Among authors: egerer g. BMC Cancer. 2011 Dec 7;11:510. doi: 10.1186/1471-2407-11-510. BMC Cancer. 2011. PMID: 22152120 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters